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Background. In 1897, Dieulafoy was the ﬁrst to characterize a gaping arteriole within the gastric mucosa causing massive
hematemesis, designating it as “exulceratio simplex.” A hundred years later, this vascular abnormality, now commonly referred
to as a “Dieulafoy lesion,” has been identiﬁed through the entire gastrointestinal tract and the bronchus. Objectives and Methods.
As the original ﬁndings have been subjected to revisions and modiﬁcations by modern authors, Dieulafoy’s original paper was
reviewed and analyzed. The evolution of the current usage of “Dieulafoy’s lesion” in the literature has been summarized with
comparisons to the original report. Additionally, an index case of a 10-year-old female with a gastric “exulceratio simplex” is
reported with a review of previously reported paediatric Dieulafoy lesions. Conclusions. The term “Dieulafoy lesion” in modern
literaturenolongeradherestotheinitialconclusionswithregardstoitsorigin,demographics,andpresentingsymptoms.Dieulafoy
lesions remain a rare cause of gastrointestinal bleeding that can cause life-threatening haemorrhages in children.
1.Introduction
Paul Georges Dieulafoy (1839–1911), a professor of pathol-
ogy at the Faculty of Medicine in Paris, France, was the ﬁrst
todescribeaseriesof10patientswhopresentedwithmassive
hematemesis (approximately 4L of blood in less than 24
hours) due to a bleeding gastric vessel, without any evidence
of ulceration in the ﬁrst three lessons of the 1897-1898
editionof“CliniqueM´ edicaledel‘Hˆ otel-Dieu.” Atautopsy,a
superﬁcialulcerationwithagapingarteriolewasfoundinthe
gastricsubmucosa.Thelesion’sborderswerenothardenedor
projecting, and the remainder of the mucosa was in perfect
health. Dieulafoy concluded that this lesion was not a typical
gastric ulcer and named it an “exulceratio simplex,” which in
time became known as a “Dieulafoy lesion” [1].
Modern literature has broadened the original deﬁnition
of a “Dieulafoy lesion.” Initially only described in the
stomach, such ﬁndings have been additionally reported in
the rest of the gastrointestinal tract such as the esophagus
[2], duodenum [3], ileum [4], jejunum [5], colon [6], anal
canal [7], and rectum [7, 8]. Dieulafoy lesions have also been
reported as a case series in nongastrointestinal sites such as
the bronchus [9]. The advent of endoscopy has drastically
changed the process of diagnosing and treating Dieulafoy
lesions, with techniques such as endoscopic laparoscopic
banding (ELB), thermocoagulation, and injections with
adrenaline/epinephrine (EPI) as alternatives to replace sur-
gical management as was described in the mid-1800s as best-
practice management.
2.MaterialsandMethods
2.1. Objective. Dieulafoy’s original treatise published in
French was reviewed, analyzed, and translated into English
for discussion as we suspected that the original ﬁndings have
been subjected to revision with modiﬁcation by many cur-
rentauthors.Usinganindexcaseofa10-year-oldfemalewho
presented with recurrent upper gastrointestinal bleeding2 Gastroenterology Research and Practice
that necessitated a partial gastrectomy, the pathological
abnormality of the vascular anomaly in the submucosa—
“Dieulafoy lesion”—is analyzed from a historical viewpoint
of “then and now.” All published paediatric cases of Dieu-
lafoy lesions as available in PubMed and Medline have
also been retrieved and analyzed providing a comprehensive
review of paediatric Dieulafoy lesions.
Part 1: Revisiting the Past. We obtained a copy of the original
ﬁrst three lessons of “Clinique M´ edicale de l‘Hˆ otel-Dieu”
treatise written in 1897-1898 by Paul Georges Dieulafoy. The
original French paper was read and analyzed in its native
language and translated into English for detailed review and
study.
Part 2: Analyzing the Present. The deﬁnition and usage of a
“Dieulafoy lesion” in modern literature was explored. The
most widely recognized deﬁnition of a “Dieulafoy Lesion”
was retrieved from Wikipedia, an extensively accessed free
online encyclopaedia. We then researched the deﬁnition,
epidemiology/aetiology, clinical presentation, detection, and
treatment of this lesion using Google Scholar, PubMed, and
Medline. Finally, a search of PubMed and Medline limited
to the paediatric population (ages 0–18) was conducted in
the English and French languages. All references were read,
reviewed, and analyzed.
Part 3: Moving Forward: a New Paediatric Index Case. A
10-year-old female presented to the Emergency Room with
melena, hematemesis, and generalized abdominal pain. At
presentation, her haemoglobin was 6.5g/dL with a blood
pressure of 99/64. Gastroscopy identiﬁed four polypoid
lesions on the lesser curvature surrounded by an erythe-
matous and friable mucosa that was oozing blood. Multiple
mucosal biopsies showed no signiﬁcant pathological abnor-
mality. Imaging including an MRI showed no signiﬁcant
ﬁndings, and a repeat gastroscopy was unremarkable. She
was discharged home on prevacid.
A year and half later, she was admitted to the paediatric
intensive care unit (PICU) after vomiting approximately 1L
of bright red blood preceded by a one-day history of general
malaise and fatigue. She was hypotensive at presentation,
with a systolic pressure of 70mmHg and haemoglobin
of 7.5g/dL. She was stabilized by transfusion with ﬂuids
and two units of packed red blood cells (PRBCs). The
abdominal ultrasound was normal. A repeat gastroscopy
rediscovered the 4-5cm region of erythematous and friable
gastric mucosa and raised the possibility of an underlying
vascular abnormality. A second repeat MRI revealed diﬀuse
thickening of the greater curvature with several enlarged
mesenteric lymph nodes; the largest measured 5-6mm.
On laparoscopic examination, prominent, tortuous ves-
sels were seen on the lateral aspect of the greater curvature
and extensively on the posterior wall of the stomach. The
greater omentum inhibited a full visualization, and it was
decided to carry out an exploratory laparotomy to determine
the full extent of this vascular abnormality. At intraoperative
examination, mild handling of the stomach caused extensive
bleeding, which required vascular clamps and two units of
Figure 1: Intraoperative specimen of stomach at partial gastrec-
tomy showing the rich vascular abnormality seen within the pos-
terior gastric wall (arrow).
PRBCs to maintain haemostasis. No “normal” gastric wall
was visible on the posterior aspect (Figure 1) resulting in the
decision to proceed with a partial gastrectomy to include the
anterolateral and posterior walls of the stomach.
Histopathological examination of the specimen showed
a hemorrhagic area measuring 3.3 × 2.2cm with a central
0.4 × 0.4cm vascular polyp. On microscopic examination,
a large dilated tortuous vessel with evidence of ﬁbrin
thrombi and recent haemorrhage through the overlying
mucosa was identiﬁed (Figures 2(a) and 2(b)). This sub-
mucosal vessel measured up to 8.3mm in some sections.
No accompanying vein was identiﬁed. The mucosa appeared
congested with pseudopolypoid regions, and there was no
evidenceofinﬂammationorsigniﬁcanterosion.Specialstain
demonstrated the presence of elastin in the wall of the
persistent large vessel conﬁrming its arterial origin (Figures
2(c) and 2(d)). Additional sections also showed the presence
of complex anastomosing submucosal vessels with mucosal
and submucosal evidence of interstitial haemorrhage. The
diagnosis of a Dieulafoy’s lesion in the proximal stomach was
conﬁrmed.
Postoperative recovery was uneventful. As she had no
further complaints at her followup at the outpatient clinic
6 weeks later, her care has now been transferred to her family
physician.
All information provided in this paper has been com-
pletely deidentiﬁed and is thus exempted from a formal re-
view by the Ethics Committee as per our institutional policy.
3. Results and Discussion
3.1. Then: The Original Dieulafoy Lesion. Though in 1884
Gallard wrote the ﬁrst description of a patient with a
“Dieulafoy’s lesion” [10], this eponym is attributed to
the publication of Clinique M´ e d i c a l ed el ‘ H ˆ otel-Dieu de
Paris written by Paul Georges Dieulafoy. He was the ﬁrst
to characterize in detail a lesion he called “exulceratio
simplex.” In the ﬁrst three lessons of this treatise, Dieulafoy
describes 10 cases of exulceratios and notes that the features
that diﬀerentiate these lesions from ulcers are caused by
tuberculosis, syphilis, typhoid fever, uremia, and alcoholism.Gastroenterology Research and Practice 3
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Figure 2: Histopathological ﬁndings. (a) Whole-mount scan of hematoxylin and eosin stained slide showing the exulceratio simplex (∗)i n
the submucosa (SM) (below the mucosa (M)) as described by Dieulafoy. Additionally, (#) shows the presence of a complex rich anastomosis
of varying sized vessels in the submucosa with an intraluminal haemorrhagic thrombus (cirsoid aneurysm of gastric vessels). (b) Low
magniﬁcation (objective lens ×2) of hematoxylin and eosin-stained slides shows the presence of blood within the large tortuous, caliber-
persistent artery () in the submucosa (SM) with evidence of rupture and haemorrhage (#) through the overlying mucosa (M). A normal-
sized submucosal arteriole (∗) is seen at the same level. (c) High magniﬁcation (objective lens ×10) of hematoxylin and eosin-stained slides
shows the presence of the large caliber-persistent artery () in the submucosa (SM)—Dieulafoy’s lesion—with communications (#) into the
overlying noninﬂamed mucosa (M). (d) High magniﬁcation (objective lens ×10) of elastin-stained slides shows the presence of elastin in
the wall (#) of the exulceratio simplex conﬁrming its arterial origin.
Histological examination of the lesion revealed “sur l’une
des petites ´ erosions crat´ eriformes, due ` al ad i s p a r i t i o nd el a
muscularis mucosae, apparaˆ ıt l` art´ eriole b´ eante” (“on one of
the small crateriform erosions, caused by disappearance of
the muscularis mucosa, appears a gaping arteriole,” page 4).
He concludes the three lessons with eight major learning
points about the “exulceratio simplex” (pages 42-43) [1]:
(1) the exulceratio simplex is “` a l’estomac, une perte de
substance tr` es superﬁcielle et assez ´ etendue” (“in the
stomach,alossofsubstanceverysuperﬁcialandfairly
extensive,” Page 42);
(2) the “exulceratio simplex” is oval, elliptical, or star
shaped and has the dimensions of a 50-centime
piece, of 1 franc or 2 francs. It is “tr` es superﬁcielle
et ne d´ epasse pas en profondeur la tunique muqueuse”
(“very superﬁcial and does not extend deeper than
the tunica mucosa,” page 42);
(3) edges of the exulceratio “n’´ e t a n tn ii n d u r ´ es ni sur-
elev´ es” (“neither indurate nor raised,” page 42) and
the gastric walls maintain their softness;
(4) the exulceratio “est un processus ulc´ ereux aigu”( “ i s
an acute ulcerative process,” page 43) that reaches a
voluminous and superﬁcial submucosal arteriole;
(5) rarely the exulceratio simplex presents with gastric
symptoms,butmoreoftenitevolves“silencieusement,
sournoisement” (“silently, slyly,” page 43) in a healthy
patient who may develop nausea, vertigo, syncope,
and large haematemeses;
(6) to diagnose exulceratio simplex, the physician must
identify a “true” haematemesis and then “acqu´ erir la4 Gastroenterology Research and Practice
certitude que la lesion ...si` ege bien ` a l’estomac” (“gain
certainty that the lesion is sitting in the stomach,”
Page 43);
(7) the exulceratio simplex is extremely serious due pri-
marily to the substantial haematemeses;
(8) the future risk of recurrence remains unknown.
3.2. Now: Dieulafoy Lesions Described in the Current Liter-
ature. In the current literature, alternative names, descrip-
tions, and criteria for Dieulafoy lesions include “caliber-
persistent artery,” “gastric aneurysm,” “gastric arterioscle-
rosis,” “submucosal arteriole malformation,” and “cirsoid
aneurysm” [11, 12]. The “exulceratio simplex” as described
in 1897 is estimated to account for 0.5–14% of upper
GI bleeding [13, 14]. It is, however, suggested that a lack
of recognition rather than true rarity may be responsible
for this low incidence [15]. Most lesions (75–95%) are
in the proximal stomach, particularly within 6cm of the
gastroesophageal junction on the lesser curve [16], yet they
have also been described in nongastric sites such as the
duodenum [3], jejunum [5], ileum [17], rectum [8], and
in nongastrointestinal sites such as the bronchus [9]. This
clearly digresses from Dieulafoy’s sixth learning point which
states that the lesion “si` ege bien ` al ` estomac” (“sits in the
stomach,” page 43) [1]. Dieulafoy lesions are more common
in men than women, at a 2:1 ratio [18] and the mean
age at presentation is within the 5th decade of life (range
50–70 years) [15]. This contrasts strongly with Dieulafoy’s
observation that “l’exulceratio ` a une predilection pour les
jeunes gens” (“the exulceratio has a predilection for young
people,” page 36) [1].
Dieulafoy lesions classically present as intermittent and
massiveGI haemorrhagewithsymptoms associated withthis
blood loss. 44% of patients report melena, 30% haemateme-
sis, 18% with both hematemesis and melena, 6% with
haematochezia, and 1% with iron-deﬁciency anemia [17]
with the mean reported haemoglobin at admission ranging
between 8.4 and 9.2g/dL [13]. In Dieulafoy’s original report,
all patients presented with acute massive haematemesis such
that his learning point no. 6 emphasizes the importance of
accurate identiﬁcation of haematemesis. He also stresses that
“les h´ emorragies stomacales dues ` al ´ exulceratio simplex sont ...
pas annonc´ ees par de petits vomissements de sang”( “ g a s t r i c
haemorrhages due to the exulceratio are not announced
by little vomits of blood,” page 32) [1]. In our index case,
however, the acute massive bleed was preceded by “little
vomits of blood” that occurred almost a year and a half
prior. Perhaps due to the older age of onset, comorbidities
are present in up to 90% of patients, the most common
including ischemic heart disease, hypertension, diabetes
mellitus, liver disease, and renal failure [12]. Interestingly
Dieulafoy commented that patients with the “exulceratio
simplex” “ressemblent ` ad e sg e n sb i e np o r t a n t s ”( “ s e e m e dl i k e
healthy people,” page 41 and conclusion no. 5) [1].
ThoughoverahundredyearshavepassedsinceDieulafoy
ﬁrst described this lesion, the mechanisms causing the
tortuosity and the persistence of the large-sized submucosal
arteries remain unknown. Many reports have attributed
this lesion to the pathological structure or the size of the
artery with a persistent musculoelastic mantle of Wanke.
Debate continues regarding the exact pathology and linkage
of this artery to the overlying mucosa [35]. Further, what
actually triggers their submucosal-to-mucosal rupture has
yet to be proven. No family predisposition [3]o rr i s kf a c t o r s
have been identiﬁed despite research that has searched for
a link with nonsteroid anti-inﬂammatory drugs (NSAIDs),
alcohol, tobacco, or a history of peptic ulcer disease [7]. The
lesion’s predominance on the lesser curve of the stomach
may be explained by the vascular architecture of this region
which arises directly from an arterial chain [15]. The
most widely accepted theory which takes into account the
paediatric cases suggests that the tortuous artery with an
increased diameter and often a variable course length is
a congenital anomaly [25]. As such, a large submucosal
artery may be abnormally close to the mucosa, facilitating its
emergence and making it more vulnerable to rupture [32].
All patients of the original series had only a single ruptured
artery, leading Dieulafoy to note that “elle passerait assez
facilement inaperc ¸ue sans un examen attentive et sans l’id´ ee
pr´ econcue qu’on va la trouver” (“it would easily enough pass
unperceived without a thorough examination and without
the preconceived idea that we will ﬁnd it,” page 24) [1].
The theories of the cause of rupture are more variable,
but it is agreed that something causing mucosal erosion
or ischemic injury must be the initial step [17]. The three
principal theories of pathogenesis include the following: (a)
pulsations of the abnormally large artery may disrupt the
mucosa and exposure of the artery to gastric/bowel contents
which then chemically or mechanically erode and cause the
bleed [12, 17], (b) gastric “wear and tear” promotes the
formation of an arterial thrombus that causes necrosis [17],
and (c) age-related atrophy [17].
The advent of endoscopy has marked a drastic change
in the diagnostic evaluation and therapeutic management
of Dieulafoy lesions. Up to 71% of initial endoscopies are
diagnostic only if there is active haemorrhage of at least
0.5mL/min [15]. However, in 6% of patients, the inter-
mittent nature of the bleeding often requires multiple
endoscopies to establish a deﬁnitive diagnosis [12, 17].
Unsuccessful endoscopies in 44% of patients are due to the
presence of excess of blood in the stomach/bowel, and the
remaining 56% are subtle lesions that are often overlooked
[12, 17]. Because of this subtlety, concomitant lesions such
as ulcers or varices may be incorrectly diagnosed as being
responsible for the bleed [13]. To diagnose a Dieulafoy
lesion, the endoscopic visual criteria that must be met
include (a) active arterial spurting or oozing from a small
(<3mm) defect in the mucosa, (b) visualization of a vessel
protruding from a slight defect or normal mucosa, and/or
(c) a fresh blood clot adherent to a defect of normal mucosa
as described by Dieulafoy [1, 16].
Should endoscopy fail to determine a source of bleeding,
angiography and capsule endoscopy may provide useful
information. On an angiogram, extravasation of contrast
into the GI system from an eroded artery is indicative of
this lesion, as is the presence of tortuous ectatic vessels in
the arterial phase without early venous return therebyGastroenterology Research and Practice 5
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distinguishing this unique lesion from arteriovenous mal-
formation [12]. This diagnostic modality is particularly
useful for colorectal lesions where poor bowel preparation
may obscure colonoscopy results [17]. A relatively new
option, capsule endoscopy, is a noninvasive, direct way of
investigating areas of the GI tract that are diﬃcult to access
by EGD or colonoscopy. There is a risk, however, of missing
these small lesions if the camera is pointed to the wrong way
and is of limited use in an emergency situation [17]. There
is limited knowledge about the use of capsule endoscopy in
children, as its size precludes its usefulness [17, 24].
Since 1986, endoscopy in addition to being the primary
diagnostic tool has also become the ﬁrst-line method of
treatment [25]. Traditionally treated with a gastrotomy or
gastrectomy, surgery is now reserved for the 4–8% of cases
that do not achieve endoscopic haemostasis [36]. The three
main forms of endoscopic treatment include (a) thermal
electrocoagulation, heat probe coagulation, argon plasma
coagulation, (b) regional injection-epinephrine (EPI) or
norepinephrine (NOR) injection and sclerotherapy, and (c)
mechanical banding and hemoclips [17, 32, 36]. A recent
studybyAlisetal.foundthatendoscopicbandligation(EBL)
was associated with a signiﬁcantly lower risk of recurrent
bleeding as well as a shorter hospital stay when compared
with sclerotherapy [36]. Monotherapy has a 9–40% higher
risk of rebleeding versus combination therapy [17]. The
site of the bleed is often tattooed with India ink for future
identiﬁcation in the event of a recurrent bleed [18]. The
overall mortality rate of Dieulafoy lesions is 8.6%, which is
constant whether treated endoscopically or surgically [12].
The mainstay of surgical treatment for endoscopic failures is
w i d ew e d g er e s e c t i o no rl o c a le x c i s i o ns u c ha sp a r t i a l / w e d g e
gastrectomy [37]. Simple oversewing of the lesion is not
recommended as it is associated with a greater risk of re-
current bleeding [37].
3.3. Pediatric Dieulafoy Lesions. Dieulafoy lesions as a cause
of massive gastrointestinal bleeding are uncommon occur-
rencesinthepaediatricpopulation.Themostcommoncause
of massive GI bleeding in children is usually related to
oesophageal varices secondary to portal hypertension and
chronic liver disease [27, 30]. These “exulceratio simplex”
are infrequent in children, and in his original description,
Dieulafoy did not encounter any children with this rare form
of gastrointestinal bleeding [1].
As listed in Table 1, twenty four cases of paediatric Dieu-
lafoy lesions have been published in the English language as
available in PubMed and Medline between 1990 and 2011
[4, 6, 7, 15, 19–34, 38–41]. Though the reported age ranged
from 8 weeks [34]t o1 8y e a r s[ 25, 32, 33], children tended to
be older, with the mean age of 10 years.
Unlike Dieulafoy lesions in the adult population, there
is no clear preponderance of these lesions in pediatric
males. Such strong male predominance in adults is perhaps
hormonally related and can be attributed to the lack of
estrogenicprotectiveeﬀectsinmales.Itisalsopostulatedthat
complex hormonal dysfunctions at the submucosal arteriole
arcade are involved in the pathogenesis of the caliber-
persistent artery as described by Dieulafoy’s illustrations on
pages 15 and 16 [1].
The location of Dieulafoy lesions reported in children
includes ten in the stomach, ﬁve in the jejunum, ﬁve in
the ileum, and two in each the duodenum, and rectum
and one in each of the sigmoid, anorectal junction, and
anal canal. Twelve children (46%) were treated surgically,
a much higher percentage than in the adult population
already described, while 14 were managed endoscopically
by injection therapy, band ligation, and thermocoagu-
lation (Table 1). Recently, minimally invasive diagnostic
and therapeutic techniques such as capsule endoscopy
assisted by laparoscopic resections, conventional bidirec-
tional endoscopy, push enteroscopy, and radionuclide imag-
ing with techniques such as multidetector-row computed
tomography (MDCT) have opened new avenues in the
management of obscure and occult gastrointestinal bleeding
inchildren[8,24].Further,GIbleedinginchildrencontinues
to pose many diﬀerent challenges to the clinician as there
is no general consensus in the investigative and treatment
protocols to be followed [24].
4. Conclusion
The usage of the term “Dieulafoy lesion” in the current
literature no longer ﬁts within the conﬁnes of the conclu-
sions drawn by its namesake over a hundred years ago.
Dissidents contest with Dieulafoy’s original theory that the
“exulceratio simplex” though of congenital origin represents
an acute process. Other digressions now include an aging
population, nongastric and extraintestinal locations, and its
recognition in children as well as in adults. Though massive
haematemesis—“gastrorrhagias”—was the sine qua non of
the “original” Dieulafoy lesion, the inclusion of nongastric
(oesophagus, duodenum, jejunum, ileum, colon, anal canal,
and rectum) and extraintestinal (bronchus) sites of this
anomaly has completely altered the clinical presentation.
Additionally, endoscopic vascular criteria have replaced the
diagnosis of this lesion in these widespread locations.
Nevertheless, the name “Dieulafoy lesion” is entrenched
in the literature and contains historical signiﬁcance; there-
fore, we suggest that this eponym may still be used with the
understanding that the diversity of the lesion it describes
no longer conforms to the original deﬁnition of the term.
Dieulafoy lesions remain a rare and most dangerous form
of gastrointestinal bleeding that can result in life-threatening
haemorrhages in children.
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